Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interviews as Topic × 90 days × Clear all

Phase

Phase NA 47 Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Neoplasms 1

Interventions

Specimen Handling 115 pembrolizumab 110 Cyclophosphamide 96 Magnetic Resonance Spectroscopy 89 Biopsy 87 fludarabine 73 Nivolumab 52 venetoclax 48 Radiotherapy 33 Cetuximab 32 fludarabine phosphate 31 Carboplatin 31 Bevacizumab 31 Paclitaxel 30 Gemcitabine 30 Fluorouracil 28 Cisplatin 28 atezolizumab 26 Azacitidine 26 durvalumab 24 Ipilimumab 24 Cytarabine 24 Injections 23 Dexamethasone 23 Temozolomide 22 Radiosurgery 22 Lenalidomide 22 Oxaliplatin 21 Irinotecan 21 Leucovorin 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡